1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Apolipoprotein E, Deficiency or Defect of: new trials by email Literature Review of Apolipoprotein E, Deficiency or Defect of trials Research Report on Apolipoprotein E, Deficiency or Defect of
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group - Cognitive Dysfunction, Alzheimer Disease | Phase 2 | Recruiting | Michal Schnaider Beeri, Ph.D. | 20 | 2025-01-12 | 2026-02-06 |
Alzheimer Disease (1) · Cognitive Dysfunction (1) · Nerve Degeneration (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Dementia (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Tauopathies (1)
Corn Oil (1) · Linseed Oil (1) · alpha-Linolenic Acid (1)
Michal Schnaider Beeri, Ph.D. (1)
United States (1)